Glenmark Pharmaceuticals
-
Glenmark, SaNOtize launch FabiSpray in India
FabiSpray will be used to treat adult patients with COVID-19 in partnership with SaNOtize Glenmark Pharmaceuticals and Canadian pharmaceutical company…
Read More » -
Glenmark receives ANDA approval for Metronidazole Vaginal Gel, 0.75%
The MetroGel-Vaginal Gel, 0.75 per cent market achieved annual sales of approximately $60.4 million Glenmark Pharmaceuticals has received final approval…
Read More » -
Glenmark Pharma receives ANDA approval for Bisoprolol Fumarate and Hydrochlorothiazide Tablets
The drugs are indicated for treating high blood pressure Glenmark Pharmaceuticals Inc, USA (Glenmark) has received final approval from the…
Read More » -
Glenmark Specialty ties up with Lotus International
The agreement will commercialise innovative nasal spray Ryaltris in Singapore, Hong Kong and Vietnam Glenmark Pharmaceuticals announced that its Swiss…
Read More » -
Glenmark receives ANDA approval for Regadenoson injection single-dose pre-filled syringe
The syringe is the generic version of Lexiscan1 Injection, 0.4 mg/5 mL (0.08 mg/mL), of Astellas US Glenmark Pharmaceuticals has…
Read More » -
Glenmark Specialty Switzerland receives NDA approval for Ryaltris Nasal Spray
Ryaltris will be marketed and distributed in the US by Hikma Specialty USA Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical…
Read More » -
Glenmark Pharma registers Q2FY22 PAT at Rs 2,577 million
The consolidated revenue has been registered at Rs 31,474 million Glenmark Pharmaceuticals announced its financial results for the second quarter…
Read More » -
Glenmark launches affordable fixed-dose combination diabetes drugs
The combination contains Remogliflozin (100 mg) + Vildagliptin (50 mg) + Metformin (500/1000 mg) in a fixed-dose and must be…
Read More » -
Glenmark launches Tavulus in Spain
Tavulus will provide relief to COPD patients in the country Glenmark Pharmaceuticals has launched a bioequivalent version of Tiotropium Bromide…
Read More »